Zevra Therapeutics Inc’s filing revealed that its Chief Legal & Compliance Thompson Rahsaan unloaded Company’s shares for reported $0.22 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Zevra Therapeutics Inc’s recent filing unveils that its Chief Legal & Compliance Thompson Rahsaan unloaded Company’s shares for reported $0.22
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Zevra Therapeutics Inc’s recent filing unveils that its Chief Legal & Compliance Thompson Rahsaan unloaded Company’s shares for reported $0.22
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Zevra Therapeutics Inc revealed its Chief Legal & Compliance Thompson Rahsaan unloaded Company’s shares for reported $0.22
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Zevra Therapeutics Inc’s filing revealed that its Chief Legal & Compliance Thompson Rahsaan unloaded Company’s shares for reported $0.22 million
Zevra Therapeutics Inc’s filing revealed that its Chief Legal & Compliance Thompson Rahsaan unloaded Company’s shares for reported $0.22 million